ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Immunotherapy in urothelial cancer, part 2: adjuvant, neoadjuvant, and adjunctive treatment. – UroToday

Immunotherapy in urothelial cancer, part 2: adjuvant, neoadjuvant, and adjunctive treatment.UroTodayThis had led to a revisitation of immunotherapy in urothelial cancer, as well as the genesis of trials using novel immunotherapeutic agents. This review… Continue reading

2017-07-29 Michael Zand NEWS

Shedding light on cause of resistance to tumor immunotherapy – Science Daily

Continue reading

2017-07-29 Michael Zand NEWS

CRISPR’d human embryos doesn’t mean designer babies are around the corner – TechCrunch

Shedding light on cause of resistance to tumor immunotherapy
Science Daily
In tumor immunotherapy, the body’s own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used. Researchers at the University of Zurich and the University …

Continue reading

2017-07-29 Michael Zand NEWS

‘No Immune Syndromes’ for Cancer Immunotherapy in HIV – Medscape


TechCrunch

CRISPR‘d human embryos doesn’t mean designer babies are around the corner
TechCrunch
Earlier this week scientists stunned us with the announcement they’d genetically altered the first human embryos in the U.S. using CRISPR technology — but don’t hold your breath if you think the ability to make designer babies is right around the corner.
Scientists Use CRISPR to Edit Human EmbryosLive Science
Editing human embryos with CRISPR is moving ahead – now’s the time to work out the ethicsThe Conversation US
Yes, US Scientists Edited an Embryo’s Genes, but Super-Babies Are a Ways AwaySlate Magazine (blog)
Mother Jones –The Lund Report –Seeker –MIT Technology Review
all 41 news articles »
Continue reading

2017-07-28 Michael Zand NEWS

CD22 CAR T-cell immunotherapy trial open for children and young adults whose leukemia escapes CD19 CAR T-cell … – Science Daily

CD22 CAR T-cell immunotherapy trial open for children and young adults whose leukemia escapes CD19 CAR T-cell …Science DailyIn PLAT-02, the CAR T cells are reprogrammed to recognize and target the CD19 protein that is expressed by most precursor B ac… Continue reading

2017-07-28 Michael Zand NEWS

If you could ‘design’ your own child, would you? – St. Augustine Record

‘No Immune Syndromes’ for Cancer Immunotherapy in HIV
Medscape
PARIS — In a small cohort of HIV-positive patients with cancers not related to HIV, immunotherapy drugs that block the PD-1 cancer pathway yielded mixed results. But the treatment was safe. “This immunotherapy could have a great impact for people with …

Continue reading

2017-07-28 Michael Zand NEWS

Big promises? Questionable stem cell therapies marketed to heart failure patients – Cardiovascular Business

Big promises? Questionable stem cell therapies marketed to heart failure patientsCardiovascular BusinessThe U.S. Food and Drug Administration (FDA) is examining potential benefits from stem cell therapies for individuals with heart failure, though it h… Continue reading

2017-07-28 Michael Zand NEWS

Q&A: Regulating Stem Cell Therapy – MedPage Today

Q&A: Regulating Stem Cell TherapyMedPage TodayEarlier this week MedPage Today reported on an influx of centers offering stem cell therapies for patients with heart failure. However, this treatment — which is marketed for a variety of conditions –… Continue reading

2017-07-28 Michael Zand NEWS
  • 1
  • …
  • 1,429
  • 1,430
  • 1,431
  • 1,432
  • 1,433
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

St. Augustine Record

If you could ‘design’ your own child, would you?
St. Augustine Record
But supporters of synthetic biology talk up huge potential long-term benefits. We could, they claim, potentially edit genes and build new ones to eradicate all hereditary diseases. With genetic alterations, we might be able to withstand anthrax attacks …
First Human Embryos Edited in USMIT Technology Review

all 35 news articles »